ATRA - Atara Biotherapeutics, Inc.
5.17
0.170 3.288%
Share volume: 3,201,173
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$5.00
0.17
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-12-2024 | 03-07-2025 | 05-15-2025 | 08-11-2025 | 11-12-2025 | |
| Cash flow financing | 24.141 M | -324.000 K | 35.793 M | -328.000 K | -250.000 K | 15.304 M | 1.047 M | |
| Other financing cash flows | -6.000 K | -454.000 K | -197.000 K | -235.000 K | 0.000 | -250.000 K | 0.000 | |
| Cash flow | 9.246 M | -3.773 M | 15.139 M | -21.423 M | -11.189 M | 2.916 M | -11.161 M | |
| Net income | -31.752 M | -19.049 M | -21.909 M | -12.693 M | 38.010 M | 2.387 M | -4.303 M | |
| Depreciation | 1.391 M | 1.330 M | 1.230 M | 1.100 M | 1.795 M | 236.000 K | 36.000 K | |
| Changes in inventories | 6.378 M | 0.000 | 0.000 | 0.000 | -10.655 M | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 14.717 M | 7.196 M | -16.665 M | 3.376 M | 17.199 M | -5.070 M | -2.421 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 127.000 K | 29.000 K | 0.000 | 90.000 K | 0.000 | 0.000 | -44.000 K | |
| Cash Change | 9.246 M | -3.773 M | 15.139 M | -21.423 M | -11.189 M | 2.916 M | -11.161 M |